Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Canafax

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|August 1, 1996
Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipientsR L Lewis, D M Canafax, K G Pettit, et al.
The Journal of Pediatrics|March 1, 1994
Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trialsR M Rosenfeld, J E Vertrees, J Carr, et al.
Transplantation Proceedings|August 1, 1985
Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisoneR L Simmons, D M Canafax, M Strand, et al.
Pharmacology|August 18, 1999
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and NeoralD M Canafax, W D Irish, H B Moran, et al.
Clinical Biochemistry|June 1, 1995
Optimizing the use of cyclosporine in renal transplantationI Sketris, R Yatscoff, P Keown, et al.
Transplantation Proceedings|February 1, 1987
A comparison of three immunosuppressive protocols in patients aged over 50 yearsD S Fryd, S K So, L Kruse, et al.
Pharmacotherapy|January 1, 1990
The pharmacoeconomics of renal transplantation: increased drug costs with decreased hospitalization costsD M Canafax, S A Gruber, G L Chan, et al.
Transplantation Proceedings|April 1, 1986
New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantationR L Simmons, D M Canafax, D S Fryd, et al.
Transplantation Proceedings|March 20, 1999
Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipientsR A Fisher, S H Pan, S J Rossi, et al.
Clinical Transplants|January 1, 1988
A comparison of two cyclosporine protocols at the University of MinnesotaD S Fryd, D M Canafax, A J Matas, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|August 1, 1996
Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipientsR L Lewis, D M Canafax, K G Pettit, et al.
The Journal of Pediatrics|March 1, 1994
Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trialsR M Rosenfeld, J E Vertrees, J Carr, et al.
Transplantation Proceedings|August 1, 1985
Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisoneR L Simmons, D M Canafax, M Strand, et al.
Pharmacology|August 18, 1999
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and NeoralD M Canafax, W D Irish, H B Moran, et al.
Clinical Biochemistry|June 1, 1995
Optimizing the use of cyclosporine in renal transplantationI Sketris, R Yatscoff, P Keown, et al.
Transplantation Proceedings|February 1, 1987
A comparison of three immunosuppressive protocols in patients aged over 50 yearsD S Fryd, S K So, L Kruse, et al.
Pharmacotherapy|January 1, 1990
The pharmacoeconomics of renal transplantation: increased drug costs with decreased hospitalization costsD M Canafax, S A Gruber, G L Chan, et al.
Transplantation Proceedings|April 1, 1986
New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantationR L Simmons, D M Canafax, D S Fryd, et al.
Transplantation Proceedings|March 20, 1999
Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipientsR A Fisher, S H Pan, S J Rossi, et al.
Clinical Transplants|January 1, 1988
A comparison of two cyclosporine protocols at the University of MinnesotaD S Fryd, D M Canafax, A J Matas, et al.
Pageof 11